lithium carbonate

Generic: lithium carbonate

Labeler: glenmark pharmaceuticals inc., usa
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name lithium carbonate
Generic Name lithium carbonate
Labeler glenmark pharmaceuticals inc., usa
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

lithium carbonate 300 mg/1

Manufacturer
Glenmark Pharmaceuticals Inc., USA

Identifiers & Regulatory

Product NDC 68462-223
Product ID 68462-223_851bb451-d546-4bc8-9c37-90b91c7ea5c5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA091544
Listing Expiration 2027-12-31
Marketing Start 2010-12-27

Pharmacologic Class

Classes
mood stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68462223
Hyphenated Format 68462-223

Supplemental Identifiers

RxCUI
197891
UPC
0368462223017
UNII
2BMD2GNA4V

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lithium carbonate (source: ndc)
Generic Name lithium carbonate (source: ndc)
Application Number ANDA091544 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-223-01)
source: ndc

Packages (1)

Ingredients (1)

lithium carbonate (300 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "851bb451-d546-4bc8-9c37-90b91c7ea5c5", "openfda": {"upc": ["0368462223017"], "unii": ["2BMD2GNA4V"], "rxcui": ["197891"], "spl_set_id": ["1b65d27e-5086-4a87-8387-c49f3d060978"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-223-01)", "package_ndc": "68462-223-01", "marketing_start_date": "20101227"}], "brand_name": "Lithium Carbonate", "product_id": "68462-223_851bb451-d546-4bc8-9c37-90b91c7ea5c5", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Mood Stabilizer [EPC]"], "product_ndc": "68462-223", "generic_name": "Lithium Carbonate", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lithium Carbonate", "active_ingredients": [{"name": "LITHIUM CARBONATE", "strength": "300 mg/1"}], "application_number": "ANDA091544", "marketing_category": "ANDA", "marketing_start_date": "20101227", "listing_expiration_date": "20271231"}